Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory David

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Cancer Biology & Therapy|July 25, 2012
Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiersGregory David
Aging|February 17, 2010
Chromatin modifications: the driving force of senescence and aging?Teresa Dimauro, Gregory David
Expert Opinion on Therapeutic Targets|January 9, 2019
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotypeLena Lau, Gregory David
Current Cancer Drug Targets|August 20, 2010
Ras-induced senescence and its physiological relevance in cancerTeresa Dimauro, Gregory David
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2016
Senescence Phenotypes Induced by Ras in Primary CellsLena Lau, Gregory David
Current Opinion in Genetics & Development|May 2, 2022
The origins of cancer cell dormancyJorge Morales-Valencia, Gregory David
Molecular & Cellular Oncology|June 17, 2016
SIN3B, the SASP, and pancreatic cancerDavid J Cantor, Gregory David
Blood|November 4, 2016
The chromatin-associated Sin3B protein is required for hematopoietic stem cell functions in miceDavid J Cantor, Gregory David
Cell Cycle (Georgetown, Tex.)|May 13, 2008
Sin3B: an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawalKathryn B Grandinetti, Gregory David
Expert Opinion on Therapeutic Targets|September 29, 2017
The potential of targeting Sin3B and its associated complexes for cancer therapyDavid J Cantor, Gregory David
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cancer Biology & Therapy|July 25, 2012
Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiersGregory David
Aging|February 17, 2010
Chromatin modifications: the driving force of senescence and aging?Teresa Dimauro, Gregory David
Expert Opinion on Therapeutic Targets|January 9, 2019
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotypeLena Lau, Gregory David
Current Cancer Drug Targets|August 20, 2010
Ras-induced senescence and its physiological relevance in cancerTeresa Dimauro, Gregory David
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2016
Senescence Phenotypes Induced by Ras in Primary CellsLena Lau, Gregory David
Current Opinion in Genetics & Development|May 2, 2022
The origins of cancer cell dormancyJorge Morales-Valencia, Gregory David
Molecular & Cellular Oncology|June 17, 2016
SIN3B, the SASP, and pancreatic cancerDavid J Cantor, Gregory David
Blood|November 4, 2016
The chromatin-associated Sin3B protein is required for hematopoietic stem cell functions in miceDavid J Cantor, Gregory David
Cell Cycle (Georgetown, Tex.)|May 13, 2008
Sin3B: an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawalKathryn B Grandinetti, Gregory David
Expert Opinion on Therapeutic Targets|September 29, 2017
The potential of targeting Sin3B and its associated complexes for cancer therapyDavid J Cantor, Gregory David
Pageof 6